RESUMO
OBJECTIVES: To determine the causes of an outbreak of lobar pneumonia. DESIGN: Matched (1:2) case-control study. SETTING: A 70-bed chronic care facility for older people. PARTICIPANTS: Residents of the facility. RESULTS: Ten residents developed pneumonia over a 10-day period. Two residents died. One case-patient had Streptococcus pneumoniae bacteremia; another had polymerase chain reaction evidence of S. pneumoniae infection. No other etiologic agent was identified. Only four of 10 case-patients had received routine diagnostic cultures of blood or sputum before the administration of antibiotics. Symptoms of upper respiratory illness (URI) among residents before the pneumonia outbreak corresponded with elevation of antibodies to human parainfluenza virus 1 (HPIV1). In a matched case-control study, six of 10 case-patients, compared with five of 20 controls, had symptoms of URI during the preceding month (matched odds ratio (MOR) = 4.5, 95% CI = 0.8-33). Nine case-patients had serum available, and five of these had both serologic evidence of recent HPIV1 infection and recent URI, compared with two of 18 controls (MOR = 9.0, 95% CI = 1.2-208). Only three residents had documentation of pneumococcal vaccination. CONCLUSIONS: Noninfluenza viral infections may play a role in the pathogenesis of some bacterial pneumonias. S. pneumoniae was the cause of at least two pneumonias; lack of preantibiotic cultures may have interfered with isolation of S. pneumoniae in others. Recent HPIV1 infection was epidemiologically linked to subsequently developing pneumonia. Spread of HPIV1 in the facility may have contributed to increased susceptibility to S. pneumoniae and, potentially, to other bacterial pathogens.
Assuntos
Anticorpos Antivirais/isolamento & purificação , Surtos de Doenças , Assistência de Longa Duração , Casas de Saúde , Infecções Pneumocócicas/epidemiologia , Pneumonia Pneumocócica/epidemiologia , Infecções Respiratórias/complicações , Infecções por Respirovirus/complicações , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Humanos , Controle de Infecções , Massachusetts/epidemiologia , Vírus da Parainfluenza 1 Humana/imunologia , Infecções Pneumocócicas/etiologia , Pneumonia Pneumocócica/etiologia , Pneumonia Pneumocócica/microbiologia , Infecções Respiratórias/virologia , Streptococcus pneumoniae/isolamento & purificaçãoRESUMO
The effects of incubation of spermatozoa with three serotypes of Ureaplasma urealyticum on spermatozoal motility and penetration in vitro were investigated. Using computer-assisted video microscopy, three parameters of motility were determined: individual path lengths, individual vectorial distances, and percentage motility. Polyacrylamide gels were used as a medium for assessment of spermatozoal penetration. Ureaplasma-infected spermatozoa did have significantly greater path lengths and individual distances than did uninfected controls, but ureaplasma infection had no significant effect on percentage motility. Overall, there were no significant differences in penetration distances between ureaplasma-infected spermatozoa and their corresponding uninfected controls. Our conclusion is that the ureaplasmas did not adversely affect motility or penetration when spermatozoa were incubated with ureaplasmas for 45 minutes at ureaplasma:sperm ratios as high as 100:1.
Assuntos
Motilidade dos Espermatozoides , Interações Espermatozoide-Óvulo , Espermatozoides/fisiologia , Ureaplasma/fisiologia , Feminino , Humanos , Masculino , Infecções por Mycoplasmatales/fisiopatologia , Sorotipagem , Ureaplasma/classificaçãoRESUMO
Invasive group A streptococcal infection has important diagnostic and therapeutic implications in patients with necrotizing fasciitis. We cared for a man with the full-blown syndrome in whom many features of toxic shock syndrome were present, including profound hypotension and renal failure. The diagnostic similarities of toxic shock syndrome and the toxic shock-like syndrome caused by group A Streptococcus could have led to inappropriate treatment. Successful therapy in our patient included high doses initially of broad-spectrum antibiotics, repeated operative debridement of the lower leg (the affected limb), and ultimately, reconstructive surgery consisting primarily of split-thickness skin grafts. The reemergence of invasive streptococcal infections may relate to changes either in virulence factors of the causative streptococcus or in exotoxins elaborated by this microorganism. A causative relationship between an exotoxin produced by group A Streptococcus and the toxic shock-like syndrome has not yet been established.
Assuntos
Fasciite/diagnóstico , Perna (Membro) , Choque Séptico/diagnóstico , Infecções Estreptocócicas/diagnóstico , Streptococcus pyogenes , Adulto , Antibacterianos/uso terapêutico , Desbridamento , Diagnóstico Diferencial , Fasciite/microbiologia , Fasciite/cirurgia , Fasciite/terapia , Humanos , Perna (Membro)/patologia , Masculino , Necrose/diagnóstico , Necrose/microbiologia , Necrose/cirurgia , Necrose/terapia , Choque Séptico/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus pyogenes/isolamento & purificaçãoRESUMO
The Meridian ImmunoCard (IC), GenBio ImmunoWELL-IgM, and Remel EIA commercial antibody tests are qualitative enzyme immunoassays that detect antibodies to Mycoplasma pneumoniae in serum. These tests were compared to an M. pneumoniae complement fixation (CF) assay, which uses a commercially available antigen component. The Meridian IC and the ImmunoWELL-IgM detect immunoglobulin M (IgM) only; the Remel EIA and the CF test detect both IgM and IgG antibodies. Detection of specific IgM antibody, which appears early in infection, can be, but is not always, indicative of a recent or current infection. Paired serum samples from 64 adult patients with probable M. pneumoniae infection were examined with each of the four tests. Thirty (47%) of the 64 acute-phase sera were IgM positive by Meridian IC, 26 (41%) were positive by Remel EIA, 24 (38%) were positive by CF, and 15 (23%) were positive by ImmunoWELL-IgM. When both the acute- and convalescent-phase serum samples from each patient were examined, 61 (95%) of the 64 patients were positive by CF, 60 patients (94%) were positive by Remel EIA, 52 patients (81%) were IgM positive by the Meridian IC, and 29 patients (45%) were IgM positive by the ImmunoWELL-IgM assay. The Meridian IC was more sensitive than the other tests for early detection of IgM antibodies. However, after examining paired serum samples, we concluded that the detection of IgM alone may not be useful for all cases of mycoplasma infection, especially in an adult population.
Assuntos
Anticorpos Antibacterianos/sangue , Testes de Fixação de Complemento/métodos , Técnicas Imunoenzimáticas , Pneumonia por Mycoplasma/sangue , Kit de Reagentes para Diagnóstico , Adulto , Anticorpos Antibacterianos/imunologia , Humanos , Mycoplasma pneumoniae/imunologia , Mycoplasma pneumoniae/isolamento & purificação , Pneumonia por Mycoplasma/imunologia , Sensibilidade e EspecificidadeRESUMO
The complement fixation (CF) test is the current reference serologic test for the diagnosis of Mycoplasma pneumoniae infection. However, it is reported to be insensitive and nonspecific, and it is labor intensive. To determine if a faster and more sensitive diagnosis of M. pneumoniae could be obtained, we examined 50 paired serum samples from patients with suspected M. pneumoniae infection by the CF test and two commercial rapid antibody detection kits, the Remel M. pneumoniae immunoglobulin G (IgG)-IgM antibody test system (Remel, Lenexa, Kans.) and the Seradyn Color Vue M. pneumoniae IgG-IgM kit (Seradyn, Indianapolis, Ind.). The Remel test, a 5-min qualitative immunobinding assay, detected antibodies in three patient serum samples with CF titers of 32 and in all but one sample with titers of > or = 64. The Seradyn test, a 40-min qualitative agglutination test, was less sensitive than CF or Remel. The Seradyn test was positive in 68% of cases, compared with 94 and 96% of cases tested by CF or Remel, respectively. Both commercial tests are faster and less technically demanding to perform than is the CF test.
Assuntos
Testes de Fixação de Complemento/métodos , Pneumonia por Mycoplasma/diagnóstico , Testes Sorológicos/métodos , Testes de Aglutinação/métodos , Testes de Aglutinação/estatística & dados numéricos , Anticorpos Antibacterianos/sangue , Testes de Fixação de Complemento/estatística & dados numéricos , Surtos de Doenças , Estudos de Avaliação como Assunto , Humanos , Técnicas Imunoenzimáticas/estatística & dados numéricos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Mycoplasma pneumoniae/imunologia , Pneumonia por Mycoplasma/epidemiologia , Pneumonia por Mycoplasma/imunologia , Sensibilidade e Especificidade , Testes Sorológicos/estatística & dados numéricos , Fatores de TempoRESUMO
PspA is an antigenically variable surface protein of Streptococcus pneumoniae that appears to be essential for full pneumococcal virulence. In addition, monoclonal antibodies to PspA protect mice against infection with specific strains of pneumococci virulent for mice. In this study, we have isolated the 43-kDa N-terminal half of the native 84-kDa PspA and determined the sequence of the first 45 amino acids. This sequence, the first obtained for a pneumococcal surface protein, is consistent with that of an amphiphatic coiled-coil alpha helix with a 7-residue periodicity common to fibrous proteins such as tropomyosin and streptococcal M protein. The 7-residue periodicity begins with residue 8 and extends throughout the remaining sequence for nearly 11 turns of the helix. Mice immunized with this purified PspA segment were protected from fatal pneumococcal challenge, thus demonstrating that those PspA epitopes eliciting protection were present in the N-terminal half of the molecule.
Assuntos
Antígenos de Superfície/isolamento & purificação , Proteínas de Bactérias/isolamento & purificação , Streptococcus pneumoniae/análise , Sequência de Aminoácidos , Animais , Antígenos de Superfície/química , Antígenos de Superfície/imunologia , Proteínas de Bactérias/química , Proteínas de Bactérias/imunologia , Vacinas Bacterianas/imunologia , Imunização , Camundongos , Camundongos Endogâmicos CBA , Dados de Sequência Molecular , Streptococcus pneumoniae/imunologiaRESUMO
Pneumococcal surface protein A (PspA) is a protection-eliciting surface protein found on all pneumococci. Although highly cross-reactive, it displays interstrain variation in its size and in the expression of individual antibody reactive epitopes. PspA was not released in significant amounts from pneumococcal membranes treated with sodium carbonate, but was solubilized with SDS. Thus, PspA is either an integral membrane protein or is attached to an integral membrane component. By SDS-PAGE and immunoblot analysis, we found two predominant molecular sizes of PspA in each strain examined. The smaller band was about the size expected from the inferred amino acid sequence of PspA and the larger band appeared to be a dimer of the monomer PspA. When higher concentrations of lysate were run on SDS gels, it was also possible to detect many additional high molecular weight components that reacted with antibodies to PspA. These multiple high molecular weight PspA bands were not due to the attachment of PspA to peptidoglycan or teichoic acids, did not appear to be composed of degraded PspA and most likely resulted from non-covalent polymerization or aggregation of PspA.
Assuntos
Antígenos de Superfície/química , Proteínas de Bactérias/química , Streptococcus pneumoniae/química , Antígenos de Superfície/metabolismo , Proteínas de Bactérias/metabolismo , Western Blotting , Membrana Celular/metabolismo , Eletroforese em Gel de Poliacrilamida , Peptidoglicano/química , Ácidos Teicoicos/química , Tripsina/químicaRESUMO
A 65-year-old man had a 3-day history of sore throat, fever, rigors, back pain, abdominal discomfort, nausea, vomiting, and diarrhea. The patient's daughter had group A streptococcus pharyngitis. The patient was found to have a ruptured abdominal aortic aneurysm. He underwent resection of the aneurysm and right axillary femoro-femoral bypass graft. The patient died 40 hours after admission. Gram stain of the aneurysm showed numerous gram-positive cocci. Group A streptococcus grew from cultures of blood, throat, and aneurysm. The group A streptococcus was M type 3, T type 3 and produced streptococcal pyrogenic exotoxin A. This case is a very rare fatal complication of group A streptococcus pharyngitis.
Assuntos
Aneurisma Infectado/microbiologia , Ruptura Aórtica/microbiologia , Bacteriemia/microbiologia , Faringite/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus pyogenes , Idoso , Aneurisma Infectado/complicações , Aorta Abdominal , Ruptura Aórtica/etiologia , Humanos , MasculinoRESUMO
Pneumococcal surface adhesin A (PsaA) is a 37-kDa surface protein present on Streptococcus pneumoniae having significant homology with fimbrial adhesion proteins. Immunization of CBA/CaHNJ Xid mice with PsaA using either complete Freund's or TiterMax adjuvants significantly protected mice against heterologous intravenous challenge with type 3 pneumococcal strain WU2 at doses up to 45 times the LD50. The results indicate that PsaA warrants further evaluation as a vaccine candidate for human pneumococcal disease.
Assuntos
Proteínas de Bactérias/imunologia , Lipoproteínas , Proteínas de Membrana Transportadoras , Complexo de Proteína do Fotossistema I , Infecções Pneumocócicas/prevenção & controle , Streptococcus pneumoniae/imunologia , Vacinas Sintéticas/imunologia , Adesinas Bacterianas , Animais , Anticorpos Antibacterianos/análise , Western Blotting , Camundongos , Camundongos Endogâmicos CBA , Infecções Pneumocócicas/imunologia , Organismos Livres de Patógenos Específicos , Vacinas Sintéticas/administração & dosagemRESUMO
A nested PCR specific for the Mycoplasma pneumoniae P1 gene was used to diagnose mycoplasma infection in two cohort patients with severe pneumonia within 24 h of tissue receipt. A postmortem diagnosis of M. pneumoniae infection was obtained for the first patient, who died without the collection of appropriate paired samples for serodiagnosis. An open-lung biopsy obtained from the second patient allowed a quick, definitive diagnosis and proper selection of therapy.
Assuntos
Pulmão/microbiologia , Mycoplasma pneumoniae/isolamento & purificação , Pneumonia por Mycoplasma/diagnóstico , Reação em Cadeia da Polimerase/métodos , Adulto , Autopsia , Biópsia , Humanos , Pulmão/patologia , MasculinoRESUMO
A new species of mycoplasmas was isolated from the lungs and nasopharyngeal washings of prairie voles (Microtus ochrogaster). Clinical signs of disease and microscopic lesions were not observed at the time of this isolation. The organism was cultured in SP4 medium; it grew aerobically, anaerobically, and in 5% CO2 in 5 to 7 days, and fermented glucose. Transmission electron microscopy revealed the organism to lack a cell wall and to have typical mycoplasmal ultrastructural morphology. The complete nucleotide sequence of the 16S rRNA gene from an isolate was determined by amplification with polymerase chain reaction and by sequencing with the dideoxynucleotide chain termination method. The sequence did not match any known sequences in the GenBank of the National Institutes of Health. The 16S rRNA sequence of the organism, Mycoplasma volis (proposed species novum), is unique and most closely resembles that of M. muris and M. iowae. Because this vole colony will be housed in rooms with other rodents, pathogenicity studies of this new species of mycoplasmas in mice and rats are underway.
Assuntos
Arvicolinae/microbiologia , Infecções por Mycoplasma/veterinária , Mycoplasma/isolamento & purificação , Animais , Sequência de Bases , Ceco/microbiologia , Feminino , Fígado/microbiologia , Pulmão/microbiologia , Microscopia Eletrônica , Dados de Sequência Molecular , Mycoplasma/genética , Mycoplasma/ultraestrutura , Infecções por Mycoplasma/patologia , Líquido da Lavagem Nasal/microbiologia , Reação em Cadeia da Polimerase , Análise de Sequência de RNARESUMO
We report four cases of necrotizing fasciitis that occurred following varicella in children ranging in age from 2 to 8 years. The only organism isolated from each of these patients was Streptococcus pyogenes or group A beta-hemolytic Streptococcus (GABHS). Each child recovered; however, three required repeated surgical debridements in addition to therapy with antibiotics. An interesting finding in these patients was the development of hyponatremia and/or hypocalcemia. M-typing and T-typing of the isolates demonstrated that the GABHS strain in two children who attended the same school was M5; M1 and M3 strains were identified in the other two children. In addition to the children described in this series, eleven other cases of children with necrotizing fasciitis following varicella have been reported in the English-language literature since 1970. We believe that these cases provide further evidence that varicella is an important risk factor for necrotizing fasciitis that is caused by more-virulent strains of GABHS.
Assuntos
Varicela/complicações , Fasciite/etiologia , Infecções Estreptocócicas/etiologia , Streptococcus pyogenes , Criança , Pré-Escolar , Feminino , Humanos , Masculino , NecroseRESUMO
Severe invasive disease associated with group A Streptococcus (GAS) has recently increased in frequency. Isolates of GAS from normally sterile sites were examined for the streptococcal pyrogenic exotoxin genes spe A, spe B and spe C to determine if they play a role in this disease. Four primers for each gene were used in a nested polymerase chain reaction (PCR) configuration. The first PCR generated fragments of 818, 1106, and 801 bp, respectively, for the extotoxin genes. The second PCR generated fragments of 500, 912 and 654 bp for the spe A, spe B and spe C genes using the fragments from the first PCR as template. Of 62 strains tested, 35 (56%) contained the spe A gene, and 17 (27%) contained the spe C gene. All GAS strains studied, regardless of disease association, contained the spe B gene. These data corroborate accumulating evidence that the genes encoding pyrogenic exotoxin types B and C are not associated with severe invasive streptococcal illness including streptococcal toxic shock-like syndrome. This PCR-based gene detection system has clinical and epidemiologic applications because of its ease of performance, non-isotope labelling, high specificity and sensitivity, and lack of requirement for purified DNA.
Assuntos
Exotoxinas/genética , Genes Bacterianos , Proteínas de Membrana , Reação em Cadeia da Polimerase/métodos , Pirogênios/genética , Streptococcus pyogenes/genética , Proteínas de Bactérias/genética , Sequência de Bases , Primers do DNA , Humanos , Dados de Sequência Molecular , Sensibilidade e Especificidade , Especificidade da Espécie , Infecções Estreptocócicas/microbiologiaRESUMO
OBJECTIVE: To determine disease incidence and changes in the epidemiology of invasive group A streptococcal infections in a community in Arizona. DESIGN AND SETTING: We retrospectively surveyed microbiology records from all 10 hospitals in Pima County, Arizona, to identify patients who had Streptococcus pyogenes isolated from blood, sterile body fluid, or tissue biopsy specimens between April 1985 and March 1990. Demographic and clinical information was abstracted from the medical records of these patients. PATIENTS: A total of 128 patients with a median age of 53.5 years (range, 6 months to 96 years). OUTCOME MEASURES: Racial/ethnic differences in disease incidence; mortality and changes in the clinical spectrum of disease over the study period. RESULTS: The annual age-adjusted incidence was 4.3 per 100,000 but was 46.0 per 100,000 among Native Americans. Advanced age, age less than 5 years, hypotension, and multi-organ system involvement were significantly associated with increased mortality. From 1985 to 1990, the proportion of infections with hypotension, rash, desquamation, renal impairment, and gastrointestinal involvement increased significantly (chi 2 for trend P < or = .02 for each feature). A toxic shock-like syndrome occurred in 8% of infections since 1988, compared with none of the infections between 1985 and 1987 (P = .04). Patients with the syndrome were younger than patients with other invasive infections (median age 15 vs 54 years, P = .02), and were less likely to have underlying medical conditions (P = .008). CONCLUSIONS: Significant changes occurred in the spectrum of invasive group A streptococcal infections in Pima County, Arizona, between 1985 and 1990. Native Americans were at increased risk of acquiring these infections. Patients with the streptococcal toxic shock-like syndrome had epidemiologic features that distinguished them from patients with other invasive infections, including younger age and less underlying illness.
Assuntos
Choque Séptico/epidemiologia , Infecções Estreptocócicas/epidemiologia , Streptococcus pyogenes , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Arizona/epidemiologia , Criança , Pré-Escolar , Humanos , Incidência , Lactente , Pessoa de Meia-Idade , Análise de Regressão , Estudos Retrospectivos , Choque Séptico/diagnóstico , Choque Séptico/mortalidade , Infecções Estreptocócicas/diagnóstico , Infecções Estreptocócicas/mortalidade , Streptococcus pyogenes/isolamento & purificaçãoRESUMO
The V-1 antigen of Mycoplasma pulmonis is exposed to the surface of the mycoplasma and has an immunoblot banding pattern that varies in vitro between and within strains. To determine if V-1 variation occurs in vivo, we infected C3H/HeNCr mice intranasally with 5 X 10(8) colony-forming units of M. pulmonis strain 5782C. We isolated M. pulmonis clones from the respiratory tracts of mice up to 28 days post-infection, then used anti-V-1 monoclonal antibody P39 to visualize their V-1 immunoblot banding patterns. By the 28th day following infection, 92% of the recovered clones had variant V-1 banding patterns. Additionally, there was a significant correlation between the severity of lung lesions and the percentage of V-1 variant clones recovered from the respiratory tracts of individual mice. These studies prove that V-1 variation does occur in vivo, and suggest that mice with more severe pulmonary lesions tend to have more V-1 variant clones as a percentage of the M. pulmonis population. Thus, variation in the V-1 protein may be a mechanism by which M. pulmonis persists in the in vivo environment, possibly by evasion of host immune surveillance or by alteration of its surface membrane to take better advantage of its environmental niche in the host.
Assuntos
Antígenos de Bactérias/genética , Antígenos de Superfície/genética , Pneumopatias/microbiologia , Infecções por Mycoplasma/patologia , Mycoplasma/patogenicidade , Animais , Western Blotting , Variação Genética , Pneumopatias/patologia , Camundongos , Camundongos Endogâmicos C3H , Mycoplasma/imunologia , Mycoplasma/isolamento & purificação , Virulência/imunologiaRESUMO
The relationships among capsular type, protein type, and penicillin resistance for capsular group 9 Streptococcus pneumoniae collected in northwestern Canada between 1974 and 1987 were examined. The group 9 relatively penicillin-resistant (RPR) isolates were of the rare 9L capsular type. Of 47 penicillin-susceptible (PS) group 9 isolates that were typed for capsule, only 1 was 9L. Among 29 PS group 9 isolates that were protein typed, 9 protein types were observed. Of the 70 RPR isolates, 51 were protein type P23, 1 was P19, and 18 could not be typed (P0). Protein types P23 differed from P0 by a single epitope on pneumococcal surface protein A. These results suggest that the Canadian P23 and P0 capsular group 9 isolates are likely subclones of a primordial 9L RPR strain.
Assuntos
Cápsulas Bacterianas/análise , Resistência às Penicilinas/genética , Streptococcus pneumoniae/efeitos dos fármacos , Anticorpos Monoclonais/imunologia , Proteínas de Bactérias/análise , Humanos , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/genéticaRESUMO
Mycoplasmas were isolated from the respiratory tracts of prairie voles (Microtus ochrogaster). This paper presents biochemical, serological and molecular genetic characterizations of those organisms and proposes a new species, Mycoplasma microti sp. nov. The type strain of Mycoplasma microti is strain IL371T (ATCC 700935T).
Assuntos
Arvicolinae/microbiologia , Mycoplasma/classificação , Sistema Respiratório/microbiologia , Animais , Técnicas de Tipagem Bacteriana , DNA Ribossômico/genética , Dados de Sequência Molecular , Mycoplasma/isolamento & purificação , RNA Ribossômico 16S/genética , Terminologia como AssuntoRESUMO
Sixty-two invasive Streptococcus pyogenes strains, including 32 strains isolated from patients with streptococcal toxic shock syndrome (STSS), were analyzed for the following phenotypic and genotypic characteristics: M-protein type, serum opacity factor production, protease production, the presence of streptococcal pyrogenic exotoxin (Spe) genes A, B, and C, and in vitro production of SpeA and SpeB. These characteristics were analyzed for possible associations with each other as well as with clinical components of STSS. M-type 1, the most commonly isolated M-type, was significantly associated with protease production. Protease activity was significantly associated with the clinical sign of soft tissue necrosis. M-type 1 and 3 strains from STSS patients were significantly associated with the clinical signs of shock and organ involvement as well as with SpeA production in vitro. Finally, the production of SpeA was significantly associated with the clinical component of shock and organ involvement as well as with rash. These data suggest that STSS does not make up a single syndrome but, rather, that the multiple STSS clinical criteria probably reflect different phenotypic characteristics of individual S. pyogenes isolates.
Assuntos
Proteínas de Bactérias , Exotoxinas/toxicidade , Proteínas de Membrana , Choque Séptico/microbiologia , Streptococcus pyogenes/patogenicidade , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Criança , Pré-Escolar , Endopeptidases/metabolismo , Exotoxinas/genética , Feminino , Genes Bacterianos , Genótipo , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Fenótipo , Coelhos , Streptococcus pyogenes/enzimologia , Streptococcus pyogenes/genéticaRESUMO
Outbreaks of Mycoplasma pneumoniae (MP) in closed communities can have a high attack rate and can last several months. Azithromycin chemoprophylaxis has not been evaluated as a means of limiting transmission. This randomized, double-blinded placebo-controlled trial of azithromycin was conducted among asymptomatic hospital employees during an MP outbreak. Oropharyngeal swabs were obtained for detection of MP by polymerase chain reaction, and questionnaires were administered to assess clinical illness. Of the 147 employees who were enrolled, 73 received azithromycin and 74 received placebo. Carriage was similar within and between groups at weeks 1 and 6 (9.6% vs. 6.7% and 10.3% vs. 13.2%, respectively). Four episodes of clinically significant respiratory illness occurred in the azithromycin group versus 16 episodes in the placebo group (protective efficacy, 75%; 95% confidence interval, 28%-91%). Use of azithromycin prophylaxis in asymptomatic persons during an MP outbreak in a closed setting may be of value in reducing clinical illness.
Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Surtos de Doenças , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Pneumonia por Mycoplasma/epidemiologia , Pneumonia por Mycoplasma/prevenção & controle , Adulto , Antibacterianos/efeitos adversos , Azitromicina/efeitos adversos , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/microbiologia , Infecção Hospitalar/prevenção & controle , Infecção Hospitalar/transmissão , Intervalo Livre de Doença , Método Duplo-Cego , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Mycoplasma pneumoniae/isolamento & purificação , Orofaringe/microbiologia , Pneumonia por Mycoplasma/microbiologia , Pneumonia por Mycoplasma/transmissãoRESUMO
Pneumococcal surface protein A (PspA) has been shown previously to elicit antibodies protective against pneumococcal infection and to be necessary for full pneumococcal virulence in mice. The protein was originally defined by the two mouse monoclonal antibodies Xi64 and Xi126, which together recognized PspA on 14% of pneumococcal isolates. Some PspA molecules reacted with both antibodies, but most reacted with only one or the other. In the present study we demonstrated that PspA is produced by all pneumococci, confirming our hypothesis that there are variants of PspA which are not detected by Xi64 and Xi126. We produced a rabbit antiserum and five additional monoclonal antibodies specific for PspA for these studies. The rabbit antiserum reacted with each of 95 pneumococcal isolated tested, comprising 16 capsular serotypes. One or more of the seven monoclonal anti-PspA antibodies reacted with 95% (53 of 57) of pneumococcal isolates tested. The specificity of the monoclonal and polyclonal antibodies to PspA was confirmed in two ways: (i) by detection of molecules on wild-type pneumococci that are identical in molecular weight to those detected in Western blots (immunoblots) with Xi64 and Xi126 and (ii) by the use of mutants of Streptococcus pneumoniae that fail to produce PspA or that produce a truncated form of PspA. By using the seven monoclonal antibodies, we observed 31 PspA types among the 57 isolates. When the 53 strains reactive with the monoclonal antibodies were analyzed by capsular type as well as by serologic type and molecular weight of PspA, we observed 50 different clonotypes of pneumococci.